Coronary Disease  >>  Tekturna (aliskiren)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
AQUARiUS, NCT00853827 / 2008-006447-40: Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Completed
3
613
US, Canada, Europe, RoW
Placebo, Aliskiren
Novartis Pharmaceuticals, The Cleveland Clinic
Coronary Artery Disease (CAD), Coronary Atherosclerosis
01/13
01/13

Download Options